ASM Microbe 2018

ASM Microbe 2018

Thirteen AWG member companies present data from their clinical and research programs at the American Society for Microbiology’s ASM Microbe 2018 meeting to be held June 7-11 in Atlanta, GA.
ASM Microbe showcases the best microbial sciences in the world and provides a one-of-a-kind forum to explore the complete spectrum of microbiology from basic science to translation and application.

Friday, June 8th

Session 012: New Agents Discovery Summary Session: Early New Antimicrobial Agents
Time: 8:45 a.m. – 10:45 a.m. ET
Location: A411 and Lounge and Learn 1, Building A, Level 4

Amplyx:
9:30 a.m. – 9:45 a.m.

Session 040: FRIDAY – CPHM Late-breakers
Time: 11:00 a.m. – 1:00 p.m. ET
Location: Exhibit and Poster Hall, Building B, Halls B2-B5

T2 Biosystems:

Session 042: CPHM02 – Antimicrobial Susceptibility Testing: Gram-Negative Bacteria
Time: 11:00 a.m. – 1:00 p.m. ET
Location: Exhibit and Poster Hall, Building B, Halls B2-B5

Melinta Therapeutics:

Session 048: FRIDAY – AAR Late-breakers
Time: 11:00 a.m. – 1:00 p.m. ET
Location: Exhibit and Poster Hall, Building B, Halls B2-B5

Cidara Therapeutics:

Melinta Therapeutics:

Session 049: AAR01 – Surveillance of AMR: Molecular Typing, Clinical & Molecular Epidemiology: Antimicrobial Surveillance Studies in HospitalsTime: 11:00 a.m. – 1:00 p.m. ET
Location: Exhibit and Poster Hall, Building B, Halls B2-B5

Melinta Therapeutics:

Theravance Biopharma:

Session 050: AAR01 – Surveillance of AMR: Molecular Typing, Clinical & Molecular Epidemiology: Molecular Typing and Evolution of Resistance in Staphylococci, Enterococci and Streptococci
Time: 11:00 a.m. – 1:00 p.m. ET
Location: Exhibit and Poster Hall, Building B, Halls B2-B5

Melinta Therapeutics:

Session 054: AAR03 – Antifungal Agents and Resistance: Agents to Treat Fungal Infections
Time: 11:00 a.m. – 1:00 p.m. ET
Location: Exhibit and Poster Hall, Building B, Halls B2-B5

Amplyx:

Cidara Therapeutics:

SCYNEXIS:

Session 056: AAR04 – Antimicrobial PK/PD & General Pharmacology: In vitro Models
Time: 11:00 a.m. – 1:00 p.m. ET
Location: Exhibit and Poster Hall, Building B, Halls B2-B5

Zavante Therapeutics:

Session 061 – AAR07 – Experimental Therapeutics: New Targets, Scaffolds, Combinations and Delivery Systems
Time: 11:00 a.m. – 1:00 p.m. ET
Location: Exhibit and Poster Hall, Building B, Halls B2-B5

Melinta Therapeutics:

Session 067: CIV01 – Clinical Studies of Adult Infectious Diseases: Skin, Bone and Joint Infections
Time: 11:00 a.m. – 1:00 p.m. ET
Location: Exhibit and Poster Hall, Building B, Halls B2-B5

Melinta Therapeutics:

Session 068: CIV01 – Clinical Studies of Adult Infectious Diseases: Urogenital Tract Infections
Time: 11:00 a.m. – 1:00 p.m. ET
Location: Exhibit and Poster Hall, Building B, Halls B2-B5

Iterum Therapeutics:

Session 150: PK/PD Optimized Antimicrobial Therapy
Time: 3:00 p.m. – 3:45 p.m. ET
Location: Lounge and Learn 2, Building A, Level 3

Spero Therapeutics:
3:10 p.m. – 3:15 p.m.

3:25 p.m. – 3:30 p.m.

 

Saturday, June 9th

Session 205: Resistant Gram-negative Pathogens in the Hospital
Time: 11:00 a.m. – 12:00 p.m. ET
Location: Exhibit and Poster Hall, Building B, Halls B2-B5, CIV Hub, Learn

Melinta Therapeutics:
11:40 a.m. – 11:50 a.m. ET

Session 218: SATURDAY – CPHM Late-breakers
Time: 11:00 a.m. – 1:00 p.m. ET
Location: Exhibit and Poster Hall, Building B, Halls B2-B5

T2 Biosystems:

Session 219: CPHM02 – Antimicrobial Susceptibility Testing: Gram-positive and Fastidious Bacteria
Time: 11:00 a.m. – 1:00 p.m. ET
Location: Exhibit and Poster Hall, Building B, Halls B2-B5

Melinta Therapeutics:

Theravance Biopharma:

Session 220: CPHM03 – Diagnostic Bacteriology: Consider the Source
Time: 11:00 a.m. – 1:00 p.m. ET
Location: Exhibit and Poster Hall, Building B, Halls B2-B5

T2 Biosystems:

Session 227: AAR01 – Surveillance of AMR: Molecular Typing, Clinical & Molecular Epidemiology: Community-associated Infections by Multidrug-Resistant Bacteria
Time: 11:00 a.m. – 1:00 p.m. ET
Location: Exhibit and Poster Hall, Building B, Halls B2-B5

Nabriva Therapeutics:

Session 233: AAR04 – Antimicrobial PK/PD & General Pharmacology: in vivo Studies
Time: 11:00 a.m. – 1:00 p.m. ET
Location: Exhibit and Poster Hall, Building B, Halls B2-B5

Nabriva Therapeutics:

Melinta Therapeutics:

Spero Therapeutics:

Session 234: AAR05 – Antimicrobial Stewardship, including Quality of Care: Global Stewardship
Time: 11:00 a.m. – 1:00 p.m. ET
Location: Exhibit and Poster Hall, Building B, Halls B2-B5

Melinta Therapeutics:

Nabriva Therapeutics:

Session 235: AAR08 – New Antimicrobial Agents and New Research Technologies: Peptide and Glycopeptide Antimicrobial Agents
Time: 11:00 a.m. – 1:00 p.m. ET
Location: Exhibit and Poster Hall, Building B, Halls B2-B5

Spero Therapeutics:

Session 236: AAR09 – Pharmacological Studies of Antimicrobial Agents Pre-NDA (Phase 2/3): New Agents between Phase 2 and FDA Approval
Time: 11:00 a.m. – 1:00 p.m. ET
Location: Exhibit and Poster Hall, Building B, Halls B2-B5

Motif Bio:

Nabriva Therapeutics:

Paratek Pharmaceuticals:

Zavante Therapeutics:

 

Session 239: 239 – CIV01 – Clinical Studies of Adult Infectious Diseases: Staphylococcal and Other Gram-positive Infections
Time: 11:00 a.m. – 1:00 p.m. ET
Location: Exhibit and Poster Hall, Building B, Halls B2-B5

Paratek Pharmaceuticals:

Session 313: New Antibacterial Drugs, New Inhibitors: What, When, How
Time: 1:30 p.m. – 4:00 p.m.
Location: A410

Melinta Therapeutics:
3:00 p.m. – 3:30p p.m.

Sunday, June 10th

Session 384: SUNDAY – HMB Late-breakers
Time: 12:45 p.m. – 2:45 p.m. ET
Location: Exhibit and Poster Hall, Building B, Halls B2-B5

ContraFect:

Session 394: SUNDAY – CPHM Late-breakers
Time: 12:45 p.m. – 2:45 p.m. ET
Location: Exhibit and Poster Hall, Building B, Halls B2-B5

Melinta Therapeutics:

T2 Biosystems:

Session 403: SUNDAY – AAR Late-breakers
Time: 12:45 p.m. – 2:45 p.m. ET

Location: Exhibit and Poster Hall, Building B, Halls B2-B5

ContraFect:

Session 404: AAR01 – Surveillance of AMR: Molecular Typing, Clinical & Molecular Epidemiology: Global Surveillance Studies
Time: 12:45 p.m. – 2:45 p.m.
Location: Exhibit and Poster Hall, Building B, Halls B2-B5

Melinta Therapeutics:

Session 410: AAR08 – New Antimicrobial Agents and New Research Technologies: Bacteriophage-Related Tools and Therapy
Time: 12:45 p.m. – 2:45 p.m. ET
Location: Exhibit and Poster Hall, Building B, Halls B2-B5

ContraFect:

Session 411: AAR08 – New Antimicrobial Agents and New Research Technologies: New Agents or Combinations that Inhibit Mycobacteria
Time: 12:45 p.m. – 2:45 p.m. ET
Location: Exhibit and Poster Hall, Building B, Halls B2-B5

Spero Therapeutics:

Session 412: AAR08 – New Antimicrobial Agents and New Research Technologies: New Cephalosporins, Penems, and Carbapenems
Time: 12:45 p.m. – 2:45 p.m.
Location: Exhibit and Poster Hall, Building B, Halls B2-B5

Iterum Therapeutics:

Spero Therapeutics:

Session 417: CIV01 – Clinical Studies of Adult Infectious Diseases: Respiratory Tract Infections
Time: 12:45 p.m. – 2:45 p.m.
Location: Exhibit and Poster Hall, Building B, Halls B2-B5

Nabriva Therapeutics:

Session 420 – CIV02 – Infection Prevention and Control: Drug-Resistant Pathogens in Hospitals
Time: 12:45 p.m. – 2:45 p.m.
Location: Exhibit and Poster Hall, Building B, Halls B2-B5

Melinta Therapeutics:

Session 495: The Clinical Microbiology Laboratory of the Future (Organized in Cooperation with ESCMID and AMMI Canada)
Time: 3:00 p.m. – 5:30 p.m.
Location: A315-A316

T2 Biosystems:
4:15 p.m. – 4:30 p.m.